Rebecca Kristeleit, Kosei Hasegawa, Domenica Lorusso, Mark M. Jones, Maikel van der Velden, Jay Zhao, R. Wendel Naumann. "A phase 3, randomized, open-label study of INCB123667 versus investigator's choice of chemotherapy in patients with platinum-resistant ovarian cancer with cyclin E1 overexpression (MAESTRA 2, ENGOT-OV95, GOG-3137).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps5642